Skip to content

Questa Bio

Active
Private limited companyfounded 20242 yrs activeGendarmendreef 51A, 1180 Ukkel, BelgiumKBO/BCE: BE 1012.743.841
Summary

The computed 12-month bankruptcy probability of Questa Bio is 3.6% (moderate). The 2025 annual accounts show negative equity (-€19,018) and a net result of -€25,018. Its solvency ranks better than 11% of 524 sector peers (fiscal year 2025). The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
Axes
Profitability0
Solvency14
Growth-
Track record67
Bankruptcy probability, 12 months
3.6% Moderate
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.9; short-term debt: 111.3% and cash: 98.6% of total assets), and equity is negative.
Credit check for your own amount and term

Open the credit simulator : see how the verdict changes with amount, term and advance.

Signals

Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 y
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Scientific research and development (NACE 72)
about 30% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
-11.3%
Return on assets
-14.8%
Age of the figures
9 mo
raises risk · Multiple establishment units
Several establishment units mean more fixed costs, and such companies fail more often than a company with one establishment.
KBO · establishment units
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-07-2026, 28 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
28 d early
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

Questa Bio was incorporated on 23 August 2024 as a Private limited company.1 The company has filed annual accounts once, for fiscal year 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
-€19,018
Total assets
€168,644
Net result
-€25,018
Working capital
-€19,018

Turnover and EBIT margin not published: the micro schema does not require them.

Key figures and ratios
2025 value
Solvency
-11.3%
Current ratio
0.90
Debt to equity
-9.87
ROA
-14.8%
Debt
€187,662
Debt ≤ 1 year
€187,662

Peer companies

Historical observation

Of the 7,663 companies that looked in July 2024 the way this one looks now, 8.2% went bankrupt within 24 months and 84% are still going.

  • Micro
  • 2 to 5 years old
  • negative equity
  • a loss of 10% of the balance sheet or more
8.2% went bankrupt
5.4% stopped otherwise
84% still going

A further 2.0% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 3.6% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.6%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 7,663 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 · 24 lines
Balance sheet Code2025
Assets
Total assets20/58€168,644
Current assets29/58€168,644
Amounts receivable within one year40/41€2,419
Other amounts receivable41€2,419
Cash at bank and in hand54/58€166,225
Equity and liabilities
Total equity and liabilities10/49€168,644
Equity10/15-€19,018
Contributions10/11€6,000
Profit (loss) carried forward14-€25,018
Amounts payable17/49€187,662
Amounts payable within one year42/48€187,662
Financial debts43€6
Credit institutions430/8€6
Trade debts44€4,935
Suppliers440/4€4,935
Other amounts payable47/48€182,721
Income statement Code2025
Gross operating margin9900-€19,572
Operating profit (loss)9901-€19,572
Financial charges65/66B€5,446
Recurring financial charges65€5,446
Profit (loss) for the period before taxes9903-€25,018
Profit (loss) for the period9904-€25,018
Profit (loss) for the period to be appropriated9905-€25,018
Appropriation of the result
Profit (loss) to be appropriated9906-€25,018

The notes to these accounts (1 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2025
Gross operating margin9900-€19,572
Operating profit (loss)9901-€19,572
Financial charges65/66B€5,446
Recurring financial charges65€5,446
Profit (loss) for the period before taxes9903-€25,018
Profit (loss) for the period9904-€25,018
Profit (loss) for the period to be appropriated9905-€25,018
Line2025
Assets
Total assets20/58€168,644
Current assets29/58€168,644
Amounts receivable within one year40/41€2,419
Other amounts receivable41€2,419
Cash at bank and in hand54/58€166,225
Equity and liabilities
Total equity and liabilities10/49€168,644
Equity10/15-€19,018
Contributions10/11€6,000
Profit (loss) carried forward14-€25,018
Amounts payable17/49€187,662
Amounts payable within one year42/48€187,662
Financial debts43€6
Credit institutions430/8€6
Trade debts44€4,935
Suppliers440/4€4,935
Other amounts payable47/48€182,721
Line2025
Profit (loss) for the period9904-€25,018
Operating cash flow (approximation)-€25,018

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2026
03-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
NBB filing
0 of 2 acts read
About the unread acts

We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Ukkel · 2 establishment units since 2024
seat establishment approximate All 2 establishment units on the map
Ground area
1.0 ha
Building footprint
1,011 m²
Volume, LiDAR
13,809 m³
2 parcels, Brussels, Wallonia · tallest building 18.8 m, ±5 floors. Linked by address, not a title deed.
2 companies at this address See who is registered here
2 establishment units
Questa Bio
Gendarmendreef 51A, 1180 UkkelScientific research and development
since 20242.364.281.760
Rue Auguste Piccard 48, 6041 Charleroi
Scientific research and development
since 20242.365.874.441
2 parcels
Wallonia 1 (50%) Brussels 1 (50%)
Parcel (capakey) Region Area Buildings Height / fl.
52028B0323/00M003 Wallonia 8,679 m² 1 · 791 m² 18.8 m · 5 fl.
21614H0029/00S000 Brussels 1,377 m² 1 · 219 m² 12.1 m · 2 fl.
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector and region

This company's figures show no positive equity and no headcount, so a size comparison is not possible. These companies share only the sector and the region. Of 762 companies in sector 72101 we hold annual accounts for 483. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded23-08-2024
Fiscal year end31-12
Activities, NACEBEL 2025
72101Research and development on biotechnology
72109Other research and development on natural sciences
E-invoicing
Not found in the Peppol register

No Peppol card under this enterprise or VAT number. That proves nothing: publishing a card is voluntary.

What can you do?

Try sending from your invoicing software; if that fails, ask the customer whether they already receive via Peppol.

If the customer is not ready yet, you may send the invoice another way, for example as a PDF; if electronically, with their agreement on a secure alternative. That invoice is valid; the customer risks a penalty. FPS Finance

Register as of 27 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.